Rubius Therapeutics Inc
NASDAQ:RUBY 3:59:59 PM EDT
Rubius Therapeutics Inc Stock, NASDAQ:RUBY
399 Binney Street, Suite 300, Cambridge, Massachusetts 02139
United States of America
Phone: +1.617.679.9600
Number of Employees: 204
Description
Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines for cancer, autoimmune diseases, hemophilia, and infectious and metabolic diseases. The company was founded by Avak Kahvejian, Jordi Mata-Fink, and Noubar Afeyan on April 26, 2013 and is headquartered in Cambridge, MA.